Single or Combined Protocols for NV-AMD

PHASE4CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

November 23, 2014

Primary Completion Date

November 24, 2016

Study Completion Date

December 29, 2016

Conditions

Age-Related Macular Degeneration

Interventions

DRUG

Bevacizumab

pro-re-nata repeated single or combined intra-vitreous injection of bevacizumab

All Listed Sponsors

collaborator

Regione Emilia-Romagna

OTHER

lead

University Hospital of Ferrara

OTHER

NCT03552770 - Single or Combined Protocols for NV-AMD | Biotech Hunter | Biotech Hunter